Literature DB >> 33570706

Generation of a Recombinant Stem Cell-Specific Human SOX2 Protein from Escherichia coli Under Native Conditions.

Madhuri Thool1,2, Chandrima Dey1, Srirupa Bhattacharyya3, S Sudhagar2, Rajkumar P Thummer4.   

Abstract

The stem cell-specific SOX2 transcription factor is critical for early embryonic development and the maintenance of embryonic and neural stem cell identity. It is also crucial for the generation of induced pluripotent and neural stem cells, thus providing immense prospect in patient-specific therapies. Here, we report soluble expression and purification of human SOX2 protein under native conditions from a bacterial system. To generate this macromolecule, we codon-optimized the protein-coding sequence and fused it to a nuclear localization signal, a protein transduction domain, and a His-tag. This was then cloned into a protein expression vector and was expressed in Escherichia coli. Subsequently, we have screened and identified the optimal expression conditions to obtain recombinant fusion protein in a soluble form and studied its expression concerning the position of fusion tags at either terminal. Furthermore, we purified two versions of recombinant SOX2 fusion proteins to homogeneity under native conditions and demonstrated that they maintained their secondary structure. This molecular tool can substitute genetic and viral forms of SOX2 to facilitate the derivation of integration-free induced pluripotent and neural stem cells. Furthermore, it can be used in elucidating its role in stem cells, various cellular processes and diseases, and for structural and biochemical studies.

Entities:  

Keywords:  E. coli; Protein expression and protein purification; Recombinant protein; SOX2; Secondary structure; Stem cell

Year:  2021        PMID: 33570706     DOI: 10.1007/s12033-021-00305-y

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  48 in total

Review 1.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

2.  Generation of induced pluripotent stem cells using recombinant proteins.

Authors:  Hongyan Zhou; Shili Wu; Jin Young Joo; Saiyong Zhu; Dong Wook Han; Tongxiang Lin; Sunia Trauger; Geoffery Bien; Susan Yao; Yong Zhu; Gary Siuzdak; Hans R Schöler; Lingxun Duan; Sheng Ding
Journal:  Cell Stem Cell       Date:  2009-04-23       Impact factor: 24.633

Review 3.  New strategies to generate induced pluripotent stem cells.

Authors:  James O'Malley; Knut Woltjen; Keisuke Kaji
Journal:  Curr Opin Biotechnol       Date:  2009-10       Impact factor: 9.740

Review 4.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

Review 5.  An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.

Authors:  Krishna Kumar Haridhasapavalan; Manash P Borgohain; Chandrima Dey; Bitan Saha; Gloria Narayan; Sachin Kumar; Rajkumar P Thummer
Journal:  Gene       Date:  2018-11-22       Impact factor: 3.688

6.  Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation.

Authors:  Hyun-Jai Cho; Choon-Soo Lee; Yoo-Wook Kwon; Jae Seung Paek; Sun-Hee Lee; Jin Hur; Eun Ju Lee; Tae-Young Roh; In-Sun Chu; Sun-Hee Leem; Youngsoo Kim; Hyun-Jae Kang; Young-Bae Park; Hyo-Soo Kim
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

7.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

Review 8.  The evolving field of induced pluripotency: recent progress and future challenges.

Authors:  Cesar A Sommer; Gustavo Mostoslavsky
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

9.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

Review 10.  Induced pluripotent stem cells in disease modelling and drug discovery.

Authors:  R Grant Rowe; George Q Daley
Journal:  Nat Rev Genet       Date:  2019-07       Impact factor: 53.242

View more
  4 in total

1.  Protein Production and Purification of a Codon-Optimized Human NGN3 Transcription Factor from E. coli.

Authors:  Gloria Narayan; Akriti Agrawal; Neha Joshi; Ranadeep Gogoi; Shirisha Nagotu; Rajkumar P Thummer
Journal:  Protein J       Date:  2021-09-22       Impact factor: 2.371

2.  Generation of biologically active recombinant human OCT4 protein from E. coli.

Authors:  Chandrima Dey; Madhuri Thool; Srirupa Bhattacharyya; S Sudhagar; Rajkumar P Thummer
Journal:  3 Biotech       Date:  2021-04-08       Impact factor: 2.406

3.  Identification of Optimal Expression Parameters and Purification of a Codon-Optimized Human GLIS1 Transcription Factor from Escherichia coli.

Authors:  Chandrima Dey; Vishalini Venkatesan; Rajkumar P Thummer
Journal:  Mol Biotechnol       Date:  2021-09-15       Impact factor: 2.695

4.  Generation of a recombinant version of a biologically active cell-permeant human HAND2 transcription factor from E. coli.

Authors:  Krishna Kumar Haridhasapavalan; Pradeep Kumar Sundaravadivelu; Neha Joshi; Nayan Jyoti Das; Anshuman Mohapatra; Udayashree Voorkara; Vishwas Kaveeshwar; Rajkumar P Thummer
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.